Shukra Pharmaceuticals Share Price
07 Aug, 2026 4:00 PM (IST)
Shukra Pharmaceuticals Performance
- Today's Low
- ₹37
- Today's High
- ₹42
- 52 Week Low
- ₹17
- 52 Week High
- ₹65
- Open Price₹37
- Previous Close₹36
- Volume3,371,911
- 50 DMA₹32.20
- 100 DMA₹33.20
- 200 DMA₹33.40
Shukra Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 18.12%
- Over 3 Month + 16.12%
- Over 6 Month -8.03%
- Over 1 Year + 100.31%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 77.8
- PEG Ratio
- 0.5
- Market Cap Cr
- 1,716
- P/B Ratio
- 19.1
- Average True Range
- 2.2
- EPS
- 0.5
- Dividend Yield
- 0
- MACD Signal
- 0.8
- RSI
- 73.3
- MFI
- 85.27
Latest Stock News Updates
The Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026 Date of Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026
- BSE India
- 1 day 8 hours ago
Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve To consider and approve Unaudited financial result for the Quarter ended on 30th June, 2026 along with the Auditor''s Limited Review Report.
- BSE India
- 1 week 1 day ago
The Board took on record and confirmed that, in accordance with the terms of the aforesaid Special Resolution and the applicable provisions of Chapter V of the SEBI ICDR Regulations, the allottees were required to bring in the differential upfront amount of Rs. 0.39 per Warrant (aggregating to Rs. 18,10,770/-), being the additional amount payable on the upfront 25% (Twenty-Five Per Cent) consideration on account of the re-computation of the issue price from Rs. 34.00 to Rs. 35.56 per Warrant, within fifteen (15) days from the date of passing of the Special Resolution. Further, Two Allottees have also paid the balance 75% (Seventy-Five Per Cent) of the Warrant Issue Price of differential consideration on or before July 13, 2026.
- BSE India
- 3 weeks 3 days ago
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹32.70
- 50 Day
- ₹32.20
- 100 Day
- ₹33.20
- 200 Day
- ₹33.40
Resistance and Support
- R3 46.40
- R2 44.20
- R1 41.60
- S1 36.80
- S2 34.60
- S3 32.00
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-06-10 | Others | Inter-alia, to consider 1. Ratification of Approval for member's resolution passed in the EGM. 2. To approve draft of notice of postal ballot. 3. Other business matters. |
| 2026-05-07 | Audited Results & Final Dividend | |
| 2026-03-16 | Others | Inter-alia, to consider 1. To review the performance of Non-Independent Directors and the Board as a whole. 2. To Review the performance of the Chairman of the Company. 3. Other business matters. |
| 2026-02-04 | Quarterly Results | (Revised) |
About Shukra Pharmaceuticals
Shukra Pharmaceuticals is engaged primarily in the business of manufacture and marketing of pharmaceutical products. View More- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Popular Stocks
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹39 As on 08 August, 2026 | 02:03
The Market Cap of Shukra Pharmaceuticals is ₹1716.3 Cr As on 08 August, 2026 | 02:03
The P/E ratio of Shukra Pharmaceuticals is 77.8 As on 08 August, 2026 | 02:03
The PB ratio of Shukra Pharmaceuticals is 19.1 As on 08 August, 2026 | 02:03
The 52 week High & Low of Shukra Pharmaceuticals is ₹65.3/₹17.1 respectively As on 08 August, 2026 | 02:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.